PRAGMA PHARMACEUTICALS – Trademark Portfolio

Entity Type: 16

PRAGMA PHARMACEUTICALS holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 33 (Wine & Spirits) across 2 Nice Classification classes. Currently, 7 trademarks are registered and 2 are pending. Notable registered marks include KEFLEX, AVACLYR, MOXATAG, DECADRON, and KEFLEX 250 MG. The owner is based in LOCUST VALLEY, NY.

134 BIRCH HILL RD

LOCUST VALLEY, NY 11560

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PRAGMA PHARMACEUTICALS's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (19 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

33
Wine & Spirits (1 filing)

Alcoholic beverages (except beers)

Frequently Asked Questions

How many trademarks does PRAGMA PHARMACEUTICALS have?

PRAGMA PHARMACEUTICALS has 20 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 pending, 10 abandoned, 1 cancelled.

What trademark classes does PRAGMA PHARMACEUTICALS file in?

PRAGMA PHARMACEUTICALS files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 33 (Wine & Spirits). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are PRAGMA PHARMACEUTICALS's most well-known trademarks?

PRAGMA PHARMACEUTICALS's registered trademark portfolio includes well-known marks such as KEFLEX, AVACLYR, MOXATAG, DECADRON, and KEFLEX 250 MG. These are among 7 currently registered trademarks in the portfolio.

What is PRAGMA PHARMACEUTICALS's trademark registration success rate?

PRAGMA PHARMACEUTICALS has a 39% trademark registration rate, with 7 out of 18 resolved applications resulting in successful registration. Currently, 2 applications are pending review.